Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D01KMR | ||||
| Former ID | DCL000895 | ||||
| Drug Name | Neramexane | ||||
| Synonyms | Neramexane [INN]; Mrz 2579; MRZ 2-579; 1,3,3,5,5-Pentamethylcyclohexanamine; 1,3,3,5,5-pentamethylcyclohexan-1-amine | ||||
| Drug Type | Small molecular drug | ||||
| Indication | Cancer pain [ICD9: 140-229, 338,780; ICD10:R52, G89] | Phase 2 | [536058] | ||
| Therapeutic Class | Analgesics | ||||
| Company | Merz Pharmaceuticals GmbH | ||||
| Formula | C11H23N | ||||
| Canonical SMILES | CC1(CC(CC(C1)(C)N)(C)C)C | ||||
| InChI | 1S/C11H23N/c1-9(2)6-10(3,4)8-11(5,12)7-9/h6-8,12H2,1-5H3 | ||||
| InChIKey | OGZQTTHDGQBLBT-UHFFFAOYSA-N | ||||
| CAS Number | CAS 219810-59-0 | ||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | NMDA receptor | Target Info | Antagonist | [536058] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
